Hobbs Group Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Hobbs Group Advisors's BMY Position: Q4 2024 in Review
Hobbs Group Advisors sold out of Bristol-Myers Squibb (BMY) in Q4 2024, closing a stake of 281 shares — an estimated $14.5K sold.
Hobbs Group Advisors first reported a position in BMY in Q4 2023 and held it in 3 quarters. The position peaked at $67.1K in Q4 2023. 2,494 funds tracked by Wall St. Rank hold BMY as of Q4 2024.
- Hobbs Group Advisors reported no remaining Bristol-Myers Squibb position as of Q4 2024 after selling out during the quarter.
- Hobbs Group Advisors sold 281 Bristol-Myers Squibb shares in Q4 2024, an estimated $14.5K.
- Hobbs Group Advisors first reported a position in Bristol-Myers Squibb in Q4 2023 and held it in 3 quarters.
- Hobbs Group Advisors's Bristol-Myers Squibb position peaked at $67.1K in Q4 2023.
- 2,494 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2024.
Based on Hobbs Group Advisors's 13F filing for Q4 2024, filed 12 Feb 2025.